☰

Damian D. Medici, Ph.D. - Publications

Affiliations: 
2008 Harvard University, Cambridge, MA, United States 
Area:
Biomedical Engineering, Cell Biology, Molecular Biology
Tree Info Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Medici D, Muñoz-Cánoves P, Yang PC, Brunelli S. Mesenchymal Transitions in Development and Disease. Stem Cells International. 2016: 5107517. PMID 27563313 DOI: 10.1155/2016/5107517  0.45
2016 Medici D. Endothelial-Mesenchymal Transition in Regenerative Medicine Stem Cells International. 2016: 6962801-6962801. PMID 27143978 DOI: 10.1155/2016/6962801  0.419
2015 Liang OD, Reginato AM, Medici D. Apyrase as a novel therapeutic inhibitor of heterotopic ossification. Annals of Translational Medicine. 3: 32. PMID 26046079 DOI: 10.3978/J.Issn.2305-5839.2015.03.45  0.328
2014 Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Science Signaling. 7: re8. PMID 25249658 DOI: 10.1126/Scisignal.2005189  0.402
2014 Ramirez DM, Ramirez MR, Reginato AM, Medici D. Molecular and cellular mechanisms of heterotopic ossification. Histology and Histopathology. 29: 1281-5. PMID 24796520 DOI: 10.14670/Hh-29.1281  0.397
2013 Susienka MJ, Medici D. Vascular endothelium as a novel source of stem cells for bioengineering. Biomatter. 3. PMID 23603799 DOI: 10.4161/biom.24647  0.441
2012 Medici D, Olsen BR. Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF. Plos One. 7: e42913. PMID 22900063 DOI: 10.1371/Journal.Pone.0042913  0.562
2012 Medici D, Olsen BR. The role of endothelial-mesenchymal transition in heterotopic ossification. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 1619-22. PMID 22806925 DOI: 10.1002/Jbmr.1691  0.596
2012 Medici D, Kalluri R. Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Seminars in Cancer Biology. 22: 379-84. PMID 22554794 DOI: 10.1016/J.Semcancer.2012.04.004  0.493
2012 Suh N, Paul S, Lee HJ, Yoon T, Shah N, Son AI, Reddi AH, Medici D, Sporn MB. Synthetic triterpenoids, CDDO-Imidazolide and CDDO-Ethyl amide, induce chondrogenesis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 20: 446-50. PMID 22343171 DOI: 10.1016/J.Joca.2012.01.018  0.389
2011 Medici D, Potenta S, Kalluri R. Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. The Biochemical Journal. 437: 515-20. PMID 21585337 DOI: 10.1042/Bj20101500  0.43
2011 Walsh LA, Nawshad A, Medici D. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition Matrix Biology. 30: 243-247. PMID 21477649 DOI: 10.1016/J.Matbio.2011.03.007  0.424
2011 Medici D, Olsen BR. Transforming blood vessels into bone. Cell Cycle (Georgetown, Tex.). 10: 362-3. PMID 21239889 DOI: 10.4161/Cc.10.3.14519  0.513
2011 Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Erratum: Corrigendum: Conversion of vascular endothelial cells into multipotent stem-like cells Nature Medicine. 17: 514-514. DOI: 10.1038/Nm0411-514D  0.544
2010 Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nature Medicine. 16: 1400-6. PMID 21102460 DOI: 10.1038/nm.2252  0.573
2010 Medici D, Nawshad A. Type I collagen promotes epithelial-mesenchymal transition through ILK-dependent activation of NF-κB and LEF-1 Matrix Biology. 29: 161-165. PMID 20018240 DOI: 10.1016/J.Matbio.2009.12.003  0.407
2009 Kizu A, Medici D, Kalluri R. Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. The American Journal of Pathology. 175: 1371-3. PMID 19729485 DOI: 10.2353/Ajpath.2009.090698  0.302
2008 Jinnin M, Medici D, Park L, Limaye N, Liu Y, Boscolo E, Bischoff J, Vikkula M, Boye E, Olsen BR. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nature Medicine. 14: 1236-46. PMID 18931684 DOI: 10.1038/Nm.1877  0.607
2008 Medici D, Hay ED, Olsen BR. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Molecular Biology of the Cell. 19: 4875-87. PMID 18799618 DOI: 10.1091/Mbc.E08-05-0506  0.486
2008 Medici D, Razzaque MS, Deluca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro-O M, Olsen BR, Lanske B. FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. The Journal of Cell Biology. 182: 459-65. PMID 18678710 DOI: 10.1083/Jcb.200803024  0.452
2007 Nawshad A, Medici D, Liu CC, Hay ED. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. Journal of Cell Science. 120: 1646-53. PMID 17452626 DOI: 10.1242/Jcs.003129  0.436
2006 Medici D, Hay ED, Goodenough DA. Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Molecular Biology of the Cell. 17: 1871-9. PMID 16467384 DOI: 10.1091/Mbc.E05-08-0767  0.417
Show low-probability matches.